Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

12/6/22 dh Dobutamine
December 6, 2022

From: "Donna Huggins" <donna.huggins@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Cc: "PharmTechs PSP" <psp.pharmtechs@hhsys.org>
Sent: Tuesday, December 6, 2022 10:47:13 AM
Subject: Re: Dobutamine
 
Patients currently receiving the dobutamine 250 mg / 250 ml infusions will receive PSP-prepared product until their orders are discontinued. We will not need to convert old orders to the 500 mg / 250 ml infusion

Thanks,. 
From: "Donna Huggins" <donna.huggins@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Cc: "PharmTechs PSP" <psp.pharmtechs@hhsys.org>
Sent: Tuesday, December 6, 2022 10:14:30 AM
Subject: Dobutamine
 
Dobutamine shortage update

We have reached the end of our supply of dobutamine 250 mg / 250 ml infusions. 
Starting today, we will change back to dobutamine 500 mg / 250 ml bags. 

We do have a supply of dobutamine vials available for compounding if more concentrated infusions are needed. 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved